ТШТатьяна Сергеевна Шубина

Татьяна Сергеевна Шубина

*This is an algorithmically generated author record based on publicly available information.

Татьяна Сергеевна Шубина has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endoscopic visualization of the ileum mucosa in the early diagnosis of acute graft-versus-host response after allogeneic stem cell transplantation in children

    by Татьяна Сергеевна Шубина, Maksim M. Lokhmatov, Дмитрий Николаевич Балашов, Дмитрий Сергеевич Абрамов, Ilya V. Zakharov, Илья Владимирович Захаров

    Introduction. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a cell therapy method that is widely used in hematological malignancies, solid tumors, hemoglobinopathies, primary immunodeficiencies, and other congenital diseases. One of the serious complications after allo-HSCT is graft-versus-host disease (GVHD). Acute GVHD affects the skin, liver, and gastrointestinal (GI) tract. In this connection, endoscopic diagnosis acquires special importance in the comprehensive diagnosis of gastrointestinal GVHD. The aim of the work was to determine the relationship between the severity of the clinical course of acute GVHD, visualization of villous atrophy during ileocolonoscopy and morphological changes in the mucous membrane of the terminal ileum in children after allo-HSCT. Materials and methods. There was conducted a retrospective study including forty eight 9 months–8 years patients who underwent allo-HSCT between 2020 and 2023. Depending on the presence and severity of atrophy. All 48 children were divided into four groups: group 1 included 18 (37.5%) patients with signs of pronounced atrophy according to endoscopy; group 2 included 6 (12.5%) children with mild villous atrophy; Group 3 included 7 (14.6%) patients without atrophy, but with signs of ileitis; group 4 was formed by 17 (35.4%) children without signs of inflammation of the mucous membrane of the terminal ileum. All subjects underwent ileocolonoscopy using Pentax high-resolution endoscopes (Japan), with a biopsy of the mucous membrane of the colon and ileum. Statistical data processing was performed using IBM SPSS Statistics 23 software. Results. When comparing endoscopy data with the clinical picture, there was noted a tendency to identify a more severe degree of acute GVHD in children from groups 1 and 2 with endoscopic signs of villous atrophy. Acute grade 3 GVHD was diagnosed only in children with endoscopic signs of villous atrophy — in 16.7%. In the 3rd and 4th groups of patients, there was a tendency towards more frequent detection of acute GVHD grade 0, compared to children with signs of atrophy (25% versus 8.3%); however, the differences were statistically insignificant (p > 0.05). According to histology, in the majority of patients in groups 1 and 2 (21 out of 24/87.5%), ileoscopy revealed “false” villous atrophy. In the 3rd group, not a single child showed signs of atrophy confirmed histologically, which was consistent with expectations. In 13 out of 17 (76.5%) patients of the 4th group, histological examination showed no pronounced signs of inflammation. In 3 (17.6%) children of the 4th group there were no morphological changes in the ileal mucosa. Conclusion. The clinical significance of atrophy and the prognostic value of this criterion remain controversial, which indicates to the need for continued research in this area.

  • Open Access

    Endoscopic criteria for colonic mucosal damage in children with suspected acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    by T. S. Shubina, D. N. Balashov, M. M. Lokhmatov, I. V. Zakharov, D. S. Abramov, D. G. Akhaladze

    Today, results of allogeneic hematopoietic stem cell transplantation (allo-HSCT) are very encouraging but nevertheless, 25–75% of patients still develop complications, and mortality rates reach as high as 10–19%. Two major complications of allo-HSCT are graft-versus-host disease (GVHD) and viral infections. The diagnosis of intestinal GVHD remains a challenge. Incorrect interpretation of gastrointestinal lesions may lead to grave consequences. The development of endoscopic criteria for GVHD is a major focal point in foreign literature. In our study, we included 33 patients aged 1–17 years with signs of enterocolitis and suspected isolated intestinal GVHD who had received allo-HSCT at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia between 2020 and 2023. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia. All the patients underwent white-light colonoscopy with i-scan and, if necessary, chromoendoscopy; as well as colonic mucosal biopsy for further histopathological evaluation and intestinal infection testing. Statistical analysis was performed using the IBM SPSS Statistics 23 software. Viruses were identified in the colonic mucosal samples of 84.8% of the patients. The most common pathogens were: HHV-6 (in 50% of the cases), norovirus (46.4%) and adenovirus (35.7%). The high incidence of colonic viral infections in the children with GVHD is likely the result of virus reactivation during intensive immunosuppressive therapy following allo-HSCT. In 78.8% of the study patients, the colonic mucosa had orange-peel appearance, which led us to consider such mucosal changes to be the main criterion for the endoscopic diagnosis of GVHD in children after allo-HSCT, regardless of the presence or absence of viral infections. Our study demonstrated a fairly high effectiveness of the chromoendoscopy advanced imaging technology. Further research on ways to improve methods for GVHD differential diagnosis is required.

  • INFLAMMATORY BOWEL DISEASE-LIKE CONDITIONS IN X-LINKED AGAMMAGLOBULINEMIA PATIENTS: CASE SERIES

    by Oncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology, E.K. Mgdsyan, I.N. Abramova, D.V. Yukhacheva, A.A. Mukhina, N.B. Kuzmenko, D.S. Fomina, A.A. Roppelt, A.M. Kieva, E.V. Raykina, et al.

    X-linked agammaglobulinemia (XLA) is a primary immunodeficiency (PID) characterized by defective B cell maturation, low serum immunoglobulin concentrations and recurrent infectious episodes. The disease is caused by defects of the BTK gene, which encodes Bruton's tyrosine kinase. Along with frequent infections, autoimmune complications of XLA are an important issue. Inflammatory bowel disease-like syndromes (IBD) represent a special group of complications of XLA, their pathophysiology largely unknown. Materials and methods used: Authors conducted a retrospective data analysis of 56 patients with XLA followed at the National Scientific and Practical Center for Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (Moscow, Russia) in 2011-2022. Results: IBD-like disease was diagnosed in 11 of 56 (19.6%) patients with XLA, based on medical history, endoscopic picture, histological and laboratory studies. The median onset of the first clinical manifestations of IBD was 7 years (2;14). The most common symptoms were weight loss (7/11, 64%), chronic diarrhea (7/11, 64%) and recurrent abdominal pain (5/11, 45%). Blood in the stool was detected in a quarter of the patients (3/11, 27%). Upon implementation of anti-inflammatory therapy, the majority of patients available for assessment (7/10, 70%) demonstrated improvement. Complete response to therapy with mesalazine was achieved in 2 patients out of 9 who used it (22%). Complete response to treatment with adalimumab was observed in 1 out of 4, with infliximab in 1/3, and with vedolizumab in 1/2. A single patient had refractory IBD without response to all treatment modalities, which served as an indication for allogeneic hematopoietic stem cell transplantation (HSCT), which unfortunately resulted in fatal outcome due to early post-transplant complications. Conclusion: intestinal symptoms in XLA require special vigilance and a multidisciplinary approach. In the study group, the use of variable anti-inflammatory therapy in the majority of patients was shown to be effective and did not lead to the development of additional infectious complications. Analysis of a larger number of patients with XLA and IBD would allow standardization of anti-inflammatory therapy selection in this complex group.

  • Open Access

    The role of endoscopy in the diagnosis of acute intestinal “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation

    by T. S. Shubina, I. V. Zakharov, S. G. Podlipaeva, D. S. Abramov, D. N. Balashov

    Hematopoietic stem cell transplantation (HSCT) is an effective method of therapy which is widely used for the treatment of a number of diseases in children. “Graft-versus-host” disease (GVHD) is a severe complication that can develop after HSCT. The incidence of GVHD, according to some authors, ranges from 40 to 60%. The main target organs of acute GVHD are skin, liver, and gastrointestinal tract. Early diagnosis is critical in choosing the optimal treatment. The clinical manifestations of intestinal GVHD are non-specific. Currently, the “gold standard” of GVHD diagnosis is the histopathological assessment of biopsy samples. However, a conditioning regimen, cytomegalovirus infection, and/or treatment with immunosuppressive drugs can also induce apoptosis and lead to the same microscopic changes as the ones seen in GVHD. The main goals of an endoscopic examination are the visual assessment of the mucosa and a biopsy. Several articles describe macroscopic changes in the colonic mucosa characteristic of GVHD which can be used as a diagnostic criterion. Here, we review related literature and report a case of severe acute GVHD as well as evaluate the patient’s clinical manifestations and endoscopic findings. The patient's parents gave consent to the use of their child's data, including photographs, for research purposes and in publications.


  • Open Access

    Clinical variants of esophageal stenosis caused by infectious esophagitis in children

    by S. G. Podlipaeva, I. V. Zakharov, Yu. A. Dmitrieva, T. S. Shubina, I. V. Serkova, D. V. Yukhacheva, A. V. Kuznetsova, A. Yu. Shcherbina, D. G. Akhaladze

    Infectious esophagitis (IE) is commonly seen in immunocompromised patients. IE may be the first symptom of immunodeficiency state, also can be complication of immunosuppressive therapy in patients with hematological and oncological diseases. Severe complication of IE is esophageal stenosis. Patient management tactics continue to be discussed. A purpose of our publication is to demonstrate our experience in the management of patients with infectious esophageal stenosis. The etiology, features of the clinical and endoscopic picture, as well as the effectiveness of drug therapy and endoscopic methods of treatment have been analyzed. The study was approved by the Independent Ethics Committee and the Scientific Council of the D. Rogachev NMRCPHOI. In each case, parents gave their consent to the use of their child’s data, including photographs, for research purposes and in publications.